AAAAAA

   
Results: 1-12 |
Results: 12
PRESENTATIONS FROM THE 2ND NIH SYMPOSIUM ON THERAPEUTIC OLIGONUCLEOTIDES - INTRODUCTION
Authors: CHOCHUNG YS BEAUCAGE S BERGAN R MARQUEZ V NECKERS L TORRENCE PF
Citation: Ys. Chochung et al., PRESENTATIONS FROM THE 2ND NIH SYMPOSIUM ON THERAPEUTIC OLIGONUCLEOTIDES - INTRODUCTION, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 8(2), 1998, pp. 113-114
PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL
Authors: DAWSON N FIGG WD BRAWLEY OW BERGAN R COOPER MR SENDEROWICZ A HEADLEE D STEINBERG SM SUTHERLAND M PATRONAS N SAUSVILLE E LINEHAN WM REED E SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL
Authors: DAWSON N FIGG WD BRAWLEY OW BERGAN R COOPER MR SENDEROWICZ A HEADLEE D STEINBERG SM SUTHERLAND M PATRONAS N SAUSVILLE E LINEHAN WM REED E SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
PHASE-II STUDY OF CARBOXYAMIDO-TRIAZOLE (CAI) IN ANDROGEN-INDEPENDENTPROSTATE-CANCER (AIPC)
Authors: BAUER KS FIGG WD HAMILTON JM BERGAN R CHEN A DYER V WALTHER MM LINEHAN WM REED E
Citation: Ks. Bauer et al., PHASE-II STUDY OF CARBOXYAMIDO-TRIAZOLE (CAI) IN ANDROGEN-INDEPENDENTPROSTATE-CANCER (AIPC), Annals of oncology, 9, 1998, pp. 668-668
PK-PD OF PERILLYL ALCOHOL (PAL) AND METABOLITES (METAB) IN A HUMAN PROSTATE-CANCER (PCA) MODEL SYSTEM - IMPLICATIONS FOR TDM IN CANCER
Authors: BERGAN R PATEL S KYLE E VISHNUVAJJALA B LIEBERMAN R
Citation: R. Bergan et al., PK-PD OF PERILLYL ALCOHOL (PAL) AND METABOLITES (METAB) IN A HUMAN PROSTATE-CANCER (PCA) MODEL SYSTEM - IMPLICATIONS FOR TDM IN CANCER, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 127-127
GENISTEIN-INDUCED APOPTOSIS OF PROSTATE-CANCER CELLS IS PRECEDED BY ASPECIFIC DECREASE IN FOCAL ADHESION KINASE-ACTIVITY
Authors: KYLE E NECKERS L TAKIMOTO C CURT G BERGAN R
Citation: E. Kyle et al., GENISTEIN-INDUCED APOPTOSIS OF PROSTATE-CANCER CELLS IS PRECEDED BY ASPECIFIC DECREASE IN FOCAL ADHESION KINASE-ACTIVITY, Molecular pharmacology, 51(2), 1997, pp. 193-200
GENISTEIN-STIMULATED ADHERENCE OF PROSTATE-CANCER CELLS IS ASSOCIATEDWITH THE BINDING OF FOCAL ADHESION KINASE TO BETA-1-INTEGRIN
Authors: BERGAN R KYLE E NGUYEN P TREPEL J INGUI C NECKERS L
Citation: R. Bergan et al., GENISTEIN-STIMULATED ADHERENCE OF PROSTATE-CANCER CELLS IS ASSOCIATEDWITH THE BINDING OF FOCAL ADHESION KINASE TO BETA-1-INTEGRIN, Clinical & experimental metastasis, 14(4), 1996, pp. 389-398
ELECTROPORATION OF SYNTHETIC OLIGODEOXYNUCLEOTIDES - A NOVEL TECHNIQUE FOR EX-VIVO BONE-MARROW PURGING
Authors: BERGAN R HAKIM F SCHWARTZ GN KYLE E CEPADA R SZABO JM FOWLER D GRESS R NECKERS L
Citation: R. Bergan et al., ELECTROPORATION OF SYNTHETIC OLIGODEOXYNUCLEOTIDES - A NOVEL TECHNIQUE FOR EX-VIVO BONE-MARROW PURGING, Blood, 88(2), 1996, pp. 731-741
HOW DO ANTISENSE OLIGODEOXYNUCLEOTIDES INHIBIT THE GROWTH OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS
Authors: BERGAN R NECKERS L
Citation: R. Bergan et L. Neckers, HOW DO ANTISENSE OLIGODEOXYNUCLEOTIDES INHIBIT THE GROWTH OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS, Blood, 87(9), 1996, pp. 4019-4019
APTAMERIC INHIBITION OF P210(BCR-ABL) TYROSINE KINASE AUTOPHOSPHORYLATION BY OLIGODEOXYNUCLEOTIDES OF DEFINED SEQUENCE AND BACKBONE STRUCTURE
Authors: BERGAN R CONNELL Y FAHMY B KYLE E NECKERS L
Citation: R. Bergan et al., APTAMERIC INHIBITION OF P210(BCR-ABL) TYROSINE KINASE AUTOPHOSPHORYLATION BY OLIGODEOXYNUCLEOTIDES OF DEFINED SEQUENCE AND BACKBONE STRUCTURE, Nucleic acids research, 22(11), 1994, pp. 2150-2154
ACUTE RENAL TOXICITY ASSOCIATED WITH SURAMIN IN THE TREATMENT OF PROSTATE-CANCER
Authors: FIGG WD COOPER MR THIBAULT A HEADLEE D HUMPHREY J BERGAN R REED E SARTOR O
Citation: Wd. Figg et al., ACUTE RENAL TOXICITY ASSOCIATED WITH SURAMIN IN THE TREATMENT OF PROSTATE-CANCER, Cancer, 74(5), 1994, pp. 1612-1614
ELECTROPORATION ENHANCES C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDE EFFICACY
Authors: BERGAN R CONNELL Y FAHMY B NECKERS L
Citation: R. Bergan et al., ELECTROPORATION ENHANCES C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDE EFFICACY, Nucleic acids research, 21(15), 1993, pp. 3567-3573
Risultati: 1-12 |